The previous page is sending you to https://www.streetinsider.com/Corporate+News/Adicet+Bio+%28ACET%29+Reports+Data+from+Ongoing+ADI-001+Phase+1+Trial+in+Patients+with+Relapsed+or+Refractory+Aggressive+B-Cell+Non-Hodgkin%E2%80%99s+Lymphoma/20956392.html.

 If you do not want to visit that page, you can return to the previous page.